These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 34991668)
21. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells. Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118 [TBL] [Abstract][Full Text] [Related]
22. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling. Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013 [TBL] [Abstract][Full Text] [Related]
23. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma. Tan J; Xiang L; Xu G IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930 [TBL] [Abstract][Full Text] [Related]
24. Tumor-associated macrophages promote migration and invasion via modulating IL-6/STAT3 signaling in renal cell carcinoma. Chen S; Qian S; Zhang L; Pan X; Qu F; Yu Y; Gu Z; Cui X; Shen H Int Immunopharmacol; 2022 Oct; 111():109139. PubMed ID: 35964405 [TBL] [Abstract][Full Text] [Related]
25. Isoorientin inhibits epithelial-to-mesenchymal properties and cancer stem-cell-like features in oral squamous cell carcinoma by blocking Wnt/β-catenin/STAT3 axis. Liu SC; Huang CS; Huang CM; Hsieh MS; Huang MS; Fong IH; Yeh CT; Lin CC Toxicol Appl Pharmacol; 2021 Aug; 424():115581. PubMed ID: 34019859 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma. Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760 [TBL] [Abstract][Full Text] [Related]
27. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages. Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670 [TBL] [Abstract][Full Text] [Related]
29. Oral squamous cell carcinoma suppressed antitumor immunity through induction of PD-L1 expression on tumor-associated macrophages. Jiang C; Yuan F; Wang J; Wu L Immunobiology; 2017 Apr; 222(4):651-657. PubMed ID: 28017495 [TBL] [Abstract][Full Text] [Related]
30. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487 [TBL] [Abstract][Full Text] [Related]
31. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
32. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420 [TBL] [Abstract][Full Text] [Related]
33. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p. Cai J; Qiao B; Gao N; Lin N; He W Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway. Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871 [TBL] [Abstract][Full Text] [Related]
35. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells. Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL. Yu CC; Chang YC Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715 [TBL] [Abstract][Full Text] [Related]
37. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype. Mallery SR; Wang D; Santiago B; Pei P; Schwendeman SP; Nieto K; Spinney R; Tong M; Koutras G; Han B; Holpuch A; Lang J Cancer Prev Res (Phila); 2017 Jan; 10(1):76-88. PubMed ID: 27756753 [TBL] [Abstract][Full Text] [Related]
38. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion. Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916 [TBL] [Abstract][Full Text] [Related]
39. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]